Transforming Clinical Trials with Digital Technology

The Bio Report
|

Automatic TRANSCRIPT

First. Let me congratulate you on the publication of your new book. The patient equation. Thank you like it was pretty exciting to see it in print. We're GONNA talk about clinical trials, your company Meta data, and the opportunities to capture data differently and reshape the way clinical trials are conducted. We're in this time where virtually everything we do is generating data. There's a proliferation of new means of capturing data in real time from a healthcare perspective. What's the opportunity before us to improve health and particularly the diagnosis and treatment of disease So I think that we've and somebody's Kobe nineteen is putting a magnifying glass on top of this but we've we practiced medicine pretty much since its inception by looking at data in very short little staccato timeframes. So you go to your doctor and you have your blood drawn on that particular day at that particular time You tell somebody how you were feeling that particular day at that particular time or at least try to recall how you were feeling for a period of time. But certainly wasn't something it was proactively measured. We we we get our gene sequenced and we find out what what actually happened at the moment of conception in terms of setting up our genetic future. Yes. Yes. In some diseases, obviously cancers is a perfect example, your genes. Do Mutate individual cells, but we're we're pretty much dealing with the same genes that we had over all our forty eight, forty, eight years ago. I've got today. So that is the context of thinking about what ails me, what is the right treatment for me and it's these little moments in time and I think your point about data Zuri will put its discount streaming around us everywhere, and whether it's the technology that's in our pocket or on a wrist or. Maybe things that are biologically more feasible to do not just from my know iphone perspective but can we start to monitor with medical grade sensors overtime or even just expand the dialogue with our doctors? So those conversations can happen anytime I think the big difference is that we're gonNA start to see these continuous where we actually see rate of change not just these single moments as part of how we think about diagnosing disease managing disease making sure people are getting the right treatments. That's a giant paradigm shift. That again, we've probably been waiting for literal millennia to have happened but I think we're about to to really live through that scales pretty exciting. You speak broadly in the book about the potential for data to transform healthcare I wanted to focus on clinical trials specifically. But before we do that, perhaps you can explain what metadata solutions does and as a way for listeners to understand your visibility into this world short I actually got extremely lucky in my career. If you go back twenty five years ago I thought I'd be researching one kind of cancer probably looking at maybe one gene in it. For the rest of my life and actually frustrated by the infrastructure that was available to run the research that I was doing. So how I would connect what we were doing in the laboratory with the records for patients who were volunteering to be in studies that we're working on a how he took that and turn it into something that we could publish from an academic perspective all that was very slow and cumbersome, and so with a few friends. Gins. Now, twenty five years goes when I was doing research about. Twenty years ago, twenty one years ago with friends we started what is now data and it really had the the mission of trying to help us get things from that laboratory stage into the hands of patients who are waiting for them by trying to connect all the people and all that data in a much more seamless way in a way that would allow us to accelerate the biological the medical revolutions that we were trying to power and terms of something that would really generate patient you simply put. We started connecting everybody over the Internet and we we started by connecting the professional. So people who were working scientists physicians. Statisticians that people in the life sciences, world and medical centers. Professionals Online. And this was back in the day when the only thing you could buy on Amazon Dot Com was a book. So kinda dates us a little bit but really if we can buy a book online, why can't we run our clinical trials online and and basically that's what we did fast forward twenty years and we realized a of course over the course of time that not only could be connected professionals, but we could connect the patients, and now I could we connect the patients who were volunteering to being these research projects, but we can actually connect the research projects. To each other as well. So everywhere there was a time barrier everywhere there was a systems barrier. We realized we could overcome that and create this kind of. Continuum, of data across everybody who had the same mission of getting new therapies into the marketplace, and that really has resulted instead of me being in the lab. Looking at one gene one cancer for the rest of my life. As I said getting very lucky and now I get to look at what's happening

Coming up next